Geode Capital Management’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $36.2M | Buy |
2,582,567
+35,620
| +1% | +$499K | ﹤0.01% | 1607 |
|
|
2025
Q1 | $39.8M | Buy |
2,546,947
+74,217
| +3% | +$1.16M | ﹤0.01% | 1518 |
|
|
2024
Q4 | $34.5M | Buy |
2,472,730
+2,592
| +0.1% | +$36.1K | ﹤0.01% | 1661 |
|
|
2024
Q3 | $23M | Buy |
2,470,138
+48,868
| +2% | +$455K | ﹤0.01% | 1912 |
|
|
2024
Q2 | $22.5M | Buy |
2,421,270
+449,837
| +23% | +$4.18M | ﹤0.01% | 1868 |
|
|
2024
Q1 | $19.5M | Buy |
1,971,433
+227,844
| +13% | +$2.26M | ﹤0.01% | 1945 |
|
|
2023
Q4 | $5.63M | Buy |
1,743,589
+705,643
| +68% | +$2.28M | ﹤0.01% | 2645 |
|
|
2023
Q3 | $5.51M | Buy |
1,037,946
+100,499
| +11% | +$534K | ﹤0.01% | 2586 |
|
|
2023
Q2 | $8.93M | Buy |
937,447
+129,080
| +16% | +$1.23M | ﹤0.01% | 2351 |
|
|
2023
Q1 | $8.89M | Buy |
808,367
+29,223
| +4% | +$321K | ﹤0.01% | 2328 |
|
|
2022
Q4 | $11.5M | Buy |
779,144
+44,900
| +6% | +$665K | ﹤0.01% | 2164 |
|
|
2022
Q3 | $14M | Buy |
734,244
+165,578
| +29% | +$3.16M | ﹤0.01% | 1998 |
|
|
2022
Q2 | $12.1M | Buy |
568,666
+59,285
| +12% | +$1.26M | ﹤0.01% | 2123 |
|
|
2022
Q1 | $9.81M | Buy |
509,381
+20,037
| +4% | +$386K | ﹤0.01% | 2355 |
|
|
2021
Q4 | $10.1M | Buy |
489,344
+489
| +0.1% | +$10.1K | ﹤0.01% | 2441 |
|
|
2021
Q3 | $11.7M | Buy |
488,855
+13,888
| +3% | +$332K | ﹤0.01% | 2351 |
|
|
2021
Q2 | $13M | Buy |
474,967
+43,209
| +10% | +$1.18M | ﹤0.01% | 2282 |
|
|
2021
Q1 | $12.5M | Buy |
431,758
+93,606
| +28% | +$2.71M | ﹤0.01% | 2208 |
|
|
2020
Q4 | $9.51M | Buy |
338,152
+90,239
| +36% | +$2.54M | ﹤0.01% | 2215 |
|
|
2020
Q3 | $7.26M | Buy |
247,913
+95,651
| +63% | +$2.8M | ﹤0.01% | 2163 |
|
|
2020
Q2 | $4.6M | Buy |
152,262
+91,882
| +152% | +$2.78M | ﹤0.01% | 2384 |
|
|
2020
Q1 | $1.8M | Buy |
+60,380
| New | +$1.8M | ﹤0.01% | 2726 |
|